Lista de obras -

A Randomized Trial of a Low-Trapping Nonselective N-Methyl-D-Aspartate Channel Blocker in Major Depression ⬇️

artículo científico publicado el 15 de agosto de 2013

A Randomized, placebo-controlled, crossover pilot trial of the oral selective NR2B antagonist MK-0657 in patients with treatment-resistant major depressive disorder

artículo científico publicado en 2012

A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression

artículo científico publicado en 2010

Acute stress symptoms do not worsen in posttraumatic stress disorder and abuse with a single subanesthetic dose of ketamine

artículo científico publicado en 2012

Anhedonia as a clinical correlate of suicidal thoughts in clinical ketamine trials.

artículo científico publicado en 2017

Are 24-hour motor activity patterns associated with continued rapid response to ketamine?

artículo científico publicado en 2018

Assessing measures of suicidal ideation in clinical trials with a rapid-acting antidepressant.

artículo científico publicado en 2015

Baseline delta sleep ratio predicts acute ketamine mood response in major depressive disorder ⬇️

artículo científico publicado el 5 de agosto de 2012

Brain-derived neurotrophic factor Val66Met polymorphism and antidepressant efficacy of ketamine in depressed patients.

artículo científico publicado en 2012

Brain-derived neurotrophic factor and initial antidepressant response to an N-methyl-D-aspartate antagonist.

artículo científico publicado en 2009

Clinical predictors of ketamine response in treatment-resistant major depression

artículo científico publicado en 2014

Concomitant BDNF and sleep slow wave changes indicate ketamine-induced plasticity in major depressive disorder

artículo científico publicado en 2012

Course of improvement in depressive symptoms to a single intravenous infusion of ketamine vs add-on riluzole: results from a 4-week, double-blind, placebo-controlled study

artículo científico publicado en 2012

D-serine plasma concentration is a potential biomarker of (R,S)-ketamine antidepressant response in subjects with treatment-resistant depression

artículo científico publicado en 2014

Do the dissociative side effects of ketamine mediate its antidepressant effects?

artículo científico publicado en 2014

Effect of baseline anxious depression on initial and sustained antidepressant response to ketamine.

artículo científico

Family history of alcohol dependence and antidepressant response to an N‐methyl‐D‐aspartate antagonist in bipolar depression ⬇️

artículo científico publicado el 14 de septiembre de 2012

Family history of alcohol dependence and initial antidepressant response to an N-methyl-D-aspartate antagonist

artículo científico publicado en 2008

Features of dissociation differentially predict antidepressant response to ketamine in treatment-resistant depression.

artículo científico publicado en 2018

Improvement in suicidal ideation after ketamine infusion: relationship to reductions in depression and anxiety.

artículo científico publicado en 2014

Ketamine has distinct electrophysiological and behavioral effects in depressed and healthy subjects

artículo científico publicado en 2018

Ketamine's antidepressant efficacy is extended for at least four weeks in subjects with a family history of an alcohol use disorder.

artículo científico publicado en 2014

Lithium and Valproate Levels Do Not Correlate with Ketamine's Antidepressant Efficacy in Treatment-Resistant Bipolar Depression

artículo científico publicado en 2015

Motor-Activity Markers of Circadian Timekeeping Are Related to Ketamine's Rapid Antidepressant Properties

artículo científico publicado en 2017

Neural correlates of rapid antidepressant response to ketamine in bipolar disorder.

artículo científico publicado en 2013

Neural correlates of rapid antidepressant response to ketamine in treatment-resistant unipolar depression: a preliminary positron emission tomography study.

artículo científico publicado en 2013

Rapid resolution of suicidal ideation after a single infusion of an N-methyl-D-aspartate antagonist in patients with treatment-resistant major depressive disorder

artículo científico publicado en 2010

Rating depression over brief time intervals with the Hamilton Depression Rating Scale: standard vs. abbreviated scales

artículo científico publicado en 2014

Relationship of ketamine's plasma metabolites with response, diagnosis, and side effects in major depression

artículo científico publicado en 2012

Replication of ketamine's antidepressant efficacy in bipolar depression: a randomized controlled add-on trial

artículo científico publicado en 2012

Riluzole likely lacks antidepressant efficacy in ketamine non-responders.

artículo científico publicado en 2014

Simultaneous population pharmacokinetic modelling of ketamine and three major metabolites in patients with treatment-resistant bipolar depression

artículo científico publicado en 2012

Synaptic Potentiation Is Critical for Rapid Antidepressant Response to Ketamine in Treatment-Resistant Major Depression ⬇️

artículo científico publicado el 21 de abril de 2012

The antidepressant efficacy of subanesthetic-dose ketamine does not correlate with baseline subcortical volumes in a replication sample with major depressive disorder.

artículo científico publicado en 2017

Lista de obras de

A Randomized Trial of a Low-Trapping Nonselective N-Methyl-D-Aspartate Channel Blocker in Major Depression ⬇️

A Randomized, placebo-controlled, crossover pilot trial of the oral selective NR2B antagonist MK-0657 in patients with treatment-resistant major depressive disorder

A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression

Acute stress symptoms do not worsen in posttraumatic stress disorder and abuse with a single subanesthetic dose of ketamine

Anhedonia as a clinical correlate of suicidal thoughts in clinical ketamine trials.

Are 24-hour motor activity patterns associated with continued rapid response to ketamine?

Assessing measures of suicidal ideation in clinical trials with a rapid-acting antidepressant.

Baseline delta sleep ratio predicts acute ketamine mood response in major depressive disorder ⬇️

Brain-derived neurotrophic factor Val66Met polymorphism and antidepressant efficacy of ketamine in depressed patients.

Brain-derived neurotrophic factor and initial antidepressant response to an N-methyl-D-aspartate antagonist.

Clinical predictors of ketamine response in treatment-resistant major depression

Concomitant BDNF and sleep slow wave changes indicate ketamine-induced plasticity in major depressive disorder

Course of improvement in depressive symptoms to a single intravenous infusion of ketamine vs add-on riluzole: results from a 4-week, double-blind, placebo-controlled study

D-serine plasma concentration is a potential biomarker of (R,S)-ketamine antidepressant response in subjects with treatment-resistant depression

Do the dissociative side effects of ketamine mediate its antidepressant effects?

Effect of baseline anxious depression on initial and sustained antidepressant response to ketamine.

Family history of alcohol dependence and antidepressant response to an N‐methyl‐D‐aspartate antagonist in bipolar depression ⬇️

Family history of alcohol dependence and initial antidepressant response to an N-methyl-D-aspartate antagonist

Features of dissociation differentially predict antidepressant response to ketamine in treatment-resistant depression.

Improvement in suicidal ideation after ketamine infusion: relationship to reductions in depression and anxiety.

Ketamine has distinct electrophysiological and behavioral effects in depressed and healthy subjects

Ketamine's antidepressant efficacy is extended for at least four weeks in subjects with a family history of an alcohol use disorder.

Lithium and Valproate Levels Do Not Correlate with Ketamine's Antidepressant Efficacy in Treatment-Resistant Bipolar Depression

Motor-Activity Markers of Circadian Timekeeping Are Related to Ketamine's Rapid Antidepressant Properties

Neural correlates of rapid antidepressant response to ketamine in bipolar disorder.

Neural correlates of rapid antidepressant response to ketamine in treatment-resistant unipolar depression: a preliminary positron emission tomography study.

Rapid resolution of suicidal ideation after a single infusion of an N-methyl-D-aspartate antagonist in patients with treatment-resistant major depressive disorder

Rating depression over brief time intervals with the Hamilton Depression Rating Scale: standard vs. abbreviated scales

Relationship of ketamine's plasma metabolites with response, diagnosis, and side effects in major depression

Replication of ketamine's antidepressant efficacy in bipolar depression: a randomized controlled add-on trial

Riluzole likely lacks antidepressant efficacy in ketamine non-responders.

Simultaneous population pharmacokinetic modelling of ketamine and three major metabolites in patients with treatment-resistant bipolar depression

Synaptic Potentiation Is Critical for Rapid Antidepressant Response to Ketamine in Treatment-Resistant Major Depression ⬇️

The antidepressant efficacy of subanesthetic-dose ketamine does not correlate with baseline subcortical volumes in a replication sample with major depressive disorder.